LENEXA, Kan., Jan. 5, 2006 (PRIMEZONE) -- Mediware Information Systems, Inc. (Nasdaq:MEDW) today announced that Thomas Jefferson University Hospital is the latest hospital to select Mediware as its technology partner for implementation of technology advancements for its Blood Bank.
Thomas Jefferson University Hospital, a nineteen-year client of Mediware's Hemocare(r) product, and its Methodist Hospital Division have chosen Mediware's HCLL(tm) Transfusion and HCLL(tm) Donor solutions to improve health outcomes and system safeguards. "Mediware has proven to be dependable and reliable in its support of our staff and automation needs," said James Maratea, Administrative Director of Clinical Laboratory and Blood Bank. "Mediware's ability to support multiple facilities, aid with data conversions, assist with HIPAA compliance, and help ensure patient safety were all factors in our decision," he said.
The deployment of products for Thomas Jefferson University Hospital and Methodist Hospital will run concurrently. "The common databases and ability to better identify, track and transfer patients will contribute to operational efficiencies," noted Maratea.
Thomas Jefferson University Hospital has consistently distinguished itself as an industry leader and innovator as evidenced by its rating as one of "America's Best Hospitals" for many specialties by U.S. News & World Report for 14 years in a row. In yet another testament to the hospital's reputation for safety, innovation and medical excellence, Thomas Jefferson University Hospital has been ranked among "The Top Hospitals In America" by Modern Maturity, AARP's magazine for people over 50.
"Mediware values its longstanding relationship with Thomas Jefferson University Hospital," stated James Burgess, President and CEO of Mediware. "We are a committed partner and will continue to support Thomas Jefferson University Hospital's best medical and operational practices to further expand the reach and the benefits that advanced information technology will afford them."
About Thomas Jefferson University Hospitals
Founded in 1825, Thomas Jefferson University Hospital now has 925 licensed acute care beds, with major programs in a wide range of clinical specialties. Services are delivered among four locations including Center City, Jefferson Hospital for Neuroscience, Methodist Hospital, which is located in south Philadelphia, and Jefferson HealthCARE - Voorhees, in New Jersey and at various radiation therapy satellites throughout the region.
Thomas Jefferson University Hospital has major programs for heart disease, cancer treatment, neuroscience, high-risk childbirth, genetics, radiology, orthopedics, digestive diseases and many other areas of medicine and surgery. It is one of only a few hospitals in the United States that is both a Level I Trauma Center and a federally designated regional spinal cord injury center. Jefferson's Kimmel Cancer Center is designated as a clinical cancer center by the National Cancer Institute.
About Mediware
Mediware is a leading provider of software solutions and services for medication management, blood and cellular products and perioperative departments. With over 1,100 worldwide installations, Mediware provides hospitals, clinics, correctional institutions, blood centers and other, public and private, health care institutions with proprietary software solutions for blood donor testing and distribution, transfusion services, tissue management, cord blood processing and stem cell management, pharmacy, medication management, ordering and electronic prescribing, medication administration support beyond checking the "5 rights," patient safety alerts, clinical content, operating room scheduling, preference management, and surgical case documentation. Mediware provides a full suite of support and related services for each of its solutions. For more information about Mediware, its services and products, including HCLL(tm) Transfusion and Donor, LifeTrak(r), WORx(r), MediMAR(r), MediCOE(tm), Perioperative Solutions(tm), and JAC medicine management systems, visit www.Mediware.com.
Certain statements in this press release may constitute "forward-looking'' statements within the meaning of the Private Securities Litigation Reform Act of 1995, as the same may be amended from time to time (the "Act'') and in releases made by the SEC from time to time. Such forward-looking statements are not based on historical facts and involve known and unknown risks, uncertainties and other factors disclosed in the Company's Annual Report on Form 10-K for the year ended June 30, 2005, which may cause the actual results of the Company to be materially different from any future results expressed or implied by such forward-looking statements. The Company disclaims any obligation to update its forward-looking statements.